(NASDAQ:XAIR), GARDEN CITY, N.Y., Jan. 27, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that it plans to report the financial results for the […]
(TSX:MDP),(Frankfurt:P731), NOT FOR DISTRIBUTION TO UNITED STATES TORONTO and CHICAGO, Jan. 27, 2025 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP), is pleased to announce that it has launched an overnight marketed underwritten offering (the “Offering”) of common shares of the Company (the “Common Shares”). The Offering is expected to be
Sanmina Corporation (“Sanmina” or the “Company”) (NASDAQ: SANM), a leading integrated manufacturing solutions company, today reported financial results for the first quarter ended December 28, 2024 and outlook for its second fiscal quarter ending March 29, 2025. First Quarter Fiscal 2025 Financial Highlights• Revenue: $2.01 billion• GAAP operating margin: 4.4%• GAAP diluted EPS: $1.16• Non-GAAP(1)
AGNC Investment Corp. (“AGNC” or the “Company”) (Nasdaq: AGNC) today announced financial results for the quarter ended December 31, 2024. FOURTH QUARTER 2024 FINANCIAL HIGHLIGHTS — $(0.11) comprehensive loss per common share, comprised of: — $0.10 net income per common share — $(0.20) other comprehensive loss (“OCI”) per common share on investments marked-to-market through OCI
Gamehaus Holdings Inc.(“Gamehaus” or the “Company”) (Nasdaq: GMHS),a technology-driven mobile game publisher, today announced its official listing on the Nasdaq Capital Market (“NASDAQ”). The Company's Class A ordinary shares began trading today under the stock symbol “GMHS,” marking a pivotal step in its continued expansion and commitment to shaping the future of the global gaming
(NASDAQ:AKRO), SOUTH SAN FRANCISCO, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced today that it has commenced an underwritten public offering of $300.0 million of shares of its common stock. All of
(NASDAQ:CSX), JACKSONVILLE, Fla., Jan. 27, 2025 (GLOBE NEWSWIRE) — CSX Corporation (NASDAQ: CSX) today announced that Ann Begeman has been appointed to the company's board of directors. “Ann brings a wealth of industry expertise and knowledge to our team where she will play a vital role in our commitment to deliver service excellence and business
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=125418&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=125412&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=125411&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or